Browse Journals | AAAS - Science
www.science.org › journalDec 24, 2021 · Researchers have developed a drug to target SARS-CoV-2, the virus that causes COVID-19. The molecule, known as PF-07321332, blocks the virus’s main protease, an enzyme critical to its replication. The molecule can be delivered in pill form, which may lead to a COVID-19 treatment that can be used outside of a hospital setting. See page 1586.
Contents | Science 375, 6576
https://www.science.org/toc/science24.12.2021 · Contents | Science 374, 6575. Home Science Vol. 374, No. 6575. Back To Science. View Cover. COVER Artist's rendering of the path from a positive COVID-19 test to a potential drug treatment. Researchers have developed a drug to target SARS-CoV-2, the virus that causes COVID-19. The molecule, known as PF-07321332, blocks the virus’s main ...
Browse Journals | AAAS - Science
https://www.science.org/journal24.12.2021 · Researchers have developed a drug to target SARS-CoV-2, the virus that causes COVID-19. The molecule, known as PF-07321332, blocks the virus’s main protease, an enzyme critical to its replication. The molecule can be delivered in pill form, which may lead to a COVID-19 treatment that can be used outside of a hospital setting. See page 1586.
PNAS
https://www.pnas.orgNew Research In. Physical Sciences ... Volume 119, Issue 2: View articles in the latest issue of PNAS. Click here to view selections in the latest issue of ...
Contents | Science 375, 6576
www.science.org › toc › scienceDec 24, 2021 · Contents | Science 374, 6575. Home Science Vol. 374, No. 6575. Back To Science. View Cover. COVER Artist's rendering of the path from a positive COVID-19 test to a potential drug treatment. Researchers have developed a drug to target SARS-CoV-2, the virus that causes COVID-19. The molecule, known as PF-07321332, blocks the virus’s main ...
All Topics | Science News
www.sciencenews.org › topicsNov 18, 2021 · Science News was founded in 1921 as an independent, nonprofit source of accurate information on the latest news of science, medicine and technology. Today, our mission remains the same: to empower ...